Default company panoramic image

Avidas Pharmaceuticals, LLC

Women's healthcare company with proprietary chemical-free technology providing optimal Vitamin D absorption while ensuring sun protection.

  • Stage Prototype Ready
  • Industry Other
  • Location Doylestown, PA, USA
  • Currency USD
  • Founded October 2007
  • Employees 4
  • Website

Company Summary

Avidas' focus is the science-based dermatology market integrating health with beauty. The proprietary first generation creams/lotions focus on worldwide Vitamin D deficiency (1B persons), specific target 45M US postmenopausal women. Projected revenues are over $200M. The company's bimodal transdermal delivery has broad applications (cosmetics, nutritionals and prescription-strength products) with multiple revenue opportunities.


  • Default avatar
    Margie Gardner-Hunt
    Founder, President & CEO

    Margie has >25 years of US and ex-US success. As Sr Vice President King Pharmaceuticals she led the largest division growing revenues 14% to $1.2B. She held various global and US Leadership positions for SmithKline in Sales, Marketing, Strategy Development, Finance & Admin. As Executive Director for GSK she headed up mergers & acquisitions and grew an orphan product to market leader $40M sales. She also led Merck's $1.5B global stroke franchise.

  • Default avatar
    Charles Pamplin
    Chief Science Officer

    Dr. Pamplin most recently served as Chief of Medical Affairs King Pharmaceuticals. He is board certified in Internal Medicine with >35 years of research and drug development experience with expertise in Medical Informatics and Information Technology. He held senior positions in Quintiles and in the US Army (Retired Colonel).

  • Default avatar
    Greg Gironda
    Vice President Sales & Marketing

    Greg most recently served as Sr Director Strategic Product Development for Labopharm. He has >25 years in senior positions with PharmaCense, King, Serono and Andrx and has grown brands in highly competitive markets from $0-$70M with demonstrated expertise in new product launches.

  • Default avatar
    Jack Henn
    Business Development & Operations

    Jack most recently served as Principal, Growth Advisors LLC. He has >25 years experience in senior positions in healthcare Information technology and emerging business market development. Prior to Growth Advisors Jack was a Senior Executive for Shared Medical Systems, now Siemens.

  • Default avatar
    Shellie Unger
    Strategic Alliances and Investor Relations

    Served as Principal, Vanguard Group. She has > 25 years experience in financial services, including 7 years leading Vanguard's International Business serving European and Americas (ex-US) Institutional Investors.


  • Default avatar
    Keith Lange, Lange IP Law & Pequignot & Myers
    Default avatar
    Bob Teti, Archer Teti

Previous Investors

  • Default avatar
    Friends and family